arrow_back Back Filing freshness 10-Q Q2 FY2026 SEC EDGAR

OptimizeRx Corp

OPRX
$7.59 ▼ -0.05 (-0.65%) at close
Industrials ·Services-Business Services, NEC ·USServices-Business Services, NEC
65 Visible periods
32 Metrics
Peer-ranked Benchmarks
Price Chart
64
Health
Fair
Neutral
auto_awesome

Analytical Summary

OptimizeRx Corp shows mixed fundamentals. Consider comparing against peers in the Industrials sector before making investment decisions.

Market Cap $142.6M
Dividend Yield
Revenue Growth -29.8%
Op. Margin -0.4%
ROIC -0.0%
FCF / Share $0.46
Trailing P/E
Price / Book 1.1x
FCF Yield 6.0%
Debt / Equity 0.15
info Valuation on last close. End-of-day price, Sep 23, 2026.

65-Year Financial Trajectory

Quarterly
Metric Value Trend Year over Year Percentile
Revenue Total top-line sales
$20.50M
↓ -29.8%
Net Income Profit after all expenses
$-495.00K
↑ +77.5%
Operating Margin Operating profit as % of sales
-0.4%
↓ -121.5% 58th
FCF / Share Free cash flow per share
$0.46
↑ +1855.1%
Long-Term Debt Long-term obligations
$19.69M
↓ -16.6%

Health Breakdown

Profitability
61
Returns
51
Financial Health
68
Cash Quality
93

bar_chart Data from SEC EDGAR XBRL filings

Synced yesterday 16 years · 65 quarters